149 related articles for article (PubMed ID: 28659627)
1. Anti-parasite therapy drives changes in human visceral leishmaniasis-associated inflammatory balance.
Araújo-Santos T; Andrade BB; Gil-Santana L; Luz NF; Dos Santos PL; de Oliveira FA; Almeida ML; de Santana Campos RN; Bozza PT; Almeida RP; Borges VM
Sci Rep; 2017 Jun; 7(1):4334. PubMed ID: 28659627
[TBL] [Abstract][Full Text] [Related]
2. Serum profile of IL-1β and IL-17 cytokines in patients with visceral leishmaniasis.
Babaloo Z; Oskoei MR; Kohansal MH; Barac A; Ahmadpour E
Comp Immunol Microbiol Infect Dis; 2020 Apr; 69():101431. PubMed ID: 32059125
[TBL] [Abstract][Full Text] [Related]
3. A Defective Oxidative Burst and Impaired Antigen Presentation are Hallmarks of Human Visceral Leishmaniasis.
Roy S; Mukhopadhyay D; Mukherjee S; Ghosh S; Kumar S; Sarkar K; Pal D; Bhowmik P; Mandal K; Modak D; Guha SK; Pramanik N; Goswami RP; Saha B; Chatterjee M
J Clin Immunol; 2015 Jan; 35(1):56-67. PubMed ID: 25479930
[TBL] [Abstract][Full Text] [Related]
4. Leishmania donovani: dynamics of L. donovani evasion of innate immune cell attack due to malnutrition in visceral leishmaniasis.
Kumar V; Bimal S; Singh SK; Chaudhary R; Das S; Lal C; Pandey K; Das VR; Das P
Nutrition; 2014 Apr; 30(4):449-58. PubMed ID: 24607302
[TBL] [Abstract][Full Text] [Related]
5. Leishmania donovani: influence of anti-leishmanial therapy on expression of lymphocyte function-associated antigen-3 and its relevance to pathogenisis in visceral leishmaniasis.
Shivam P; Jamal F; Kumari S; Bimal S; Narayan S; Das VN; Pandey K; Gupta AK; Singh D; Verma N; Das P; Singh SK
Hum Immunol; 2013 Dec; 74(12):1575-8. PubMed ID: 23974052
[TBL] [Abstract][Full Text] [Related]
6. Leishmania donovani: impairment of the cellular immune response against recombinant ornithine decarboxylase protein as a possible evasion strategy of Leishmania in visceral leishmaniasis.
Yadav A; Amit A; Chaudhary R; Chandel AS; Mahantesh V; Suman SS; Singh SK; Dikhit MR; Ali V; Rabidas V; Pandey K; Kumar A; Das P; Bimal S
Int J Parasitol; 2015 Jan; 45(1):33-42. PubMed ID: 25449949
[TBL] [Abstract][Full Text] [Related]
7. Unveiling Cerebral Leishmaniasis: parasites and brain inflammation in Leishmania donovani infected mice.
Melo GD; Goyard S; Fiette L; Boissonnas A; Combadiere C; Machado GF; Minoprio P; Lang T
Sci Rep; 2017 Aug; 7(1):8454. PubMed ID: 28814754
[TBL] [Abstract][Full Text] [Related]
8. Laboratory confirmed miltefosine resistant cases of visceral leishmaniasis from India.
Srivastava S; Mishra J; Gupta AK; Singh A; Shankar P; Singh S
Parasit Vectors; 2017 Jan; 10(1):49. PubMed ID: 28137296
[TBL] [Abstract][Full Text] [Related]
9. Balance of IL-10 and interferon-gamma plasma levels in human visceral leishmaniasis: implications in the pathogenesis.
Caldas A; Favali C; Aquino D; Vinhas V; van Weyenbergh J; Brodskyn C; Costa J; Barral-Netto M; Barral A
BMC Infect Dis; 2005 Dec; 5():113. PubMed ID: 16364177
[TBL] [Abstract][Full Text] [Related]
10. Nitroimidazo-oxazole compound DNDI-VL-2098: an orally effective preclinical drug candidate for the treatment of visceral leishmaniasis.
Gupta S; Yardley V; Vishwakarma P; Shivahare R; Sharma B; Launay D; Martin D; Puri SK
J Antimicrob Chemother; 2015 Feb; 70(2):518-27. PubMed ID: 25389223
[TBL] [Abstract][Full Text] [Related]
11. Immunomodulatory effect of Arabinosylated lipoarabinomannan restrict the progression of visceral leishmaniasis through NOD2 inflammatory pathway: Functional regulation of T cell subsets.
Jawed JJ; Banerjee S; Bandyopadhyay S; Parveen S; Chowdhury BP; Saini P; Majumdar S
Biomed Pharmacother; 2018 Oct; 106():724-732. PubMed ID: 29990864
[TBL] [Abstract][Full Text] [Related]
12. 115 kDa serine protease confers sustained protection to visceral leishmaniasis caused by Leishmania donovani via IFN-γ induced down-regulation of TNF-α mediated MMP-9 activity.
Choudhury R; Das P; De T; Chakraborti T
Immunobiology; 2013 Jan; 218(1):114-26. PubMed ID: 22440312
[TBL] [Abstract][Full Text] [Related]
13. Leishmania donovani vs immunity: T-cells sensitized from Leishmania of one donor may modulate their cytokines pattern on re-stimulation with Leishmania from different donor in visceral leishmaniasis.
Narayan S; Bimal S; Singh SK; Gupta AK; Singh VP; Sinha PK; Das P
Exp Parasitol; 2009 Jan; 121(1):69-75. PubMed ID: 18948098
[TBL] [Abstract][Full Text] [Related]
14. Serum chemokine profiles in visceral leishmaniasis, HIV and HIV/ visceral leishmaniasis co-infected Ethiopian patients.
Sisay Z; Berhe N; Petros B; Tegbaru B; Messele T; Hailu A; Wolday D
Ethiop Med J; 2011 Jul; 49(3):179-86. PubMed ID: 21991751
[TBL] [Abstract][Full Text] [Related]
15. Elevated TGF-beta levels in drug-resistant visceral leishmaniasis.
Elmekki MA; Elhassan MM; Ozbak HA; Mukhtar MM
Ann Saudi Med; 2016; 36(1):73-7. PubMed ID: 26922691
[TBL] [Abstract][Full Text] [Related]
16. Therapeutic and immunomodulatory activities of short-course treatment of murine visceral leishmaniasis with KALSOME™10, a new liposomal amphotericin B.
Asad M; Bhattacharya P; Banerjee A; Ali N
BMC Infect Dis; 2015 Apr; 15():188. PubMed ID: 25884796
[TBL] [Abstract][Full Text] [Related]
17. Splenic accumulation of IL-10 mRNA in T cells distinct from CD4+CD25+ (Foxp3) regulatory T cells in human visceral leishmaniasis.
Nylén S; Maurya R; Eidsmo L; Manandhar KD; Sundar S; Sacks D
J Exp Med; 2007 Apr; 204(4):805-17. PubMed ID: 17389235
[TBL] [Abstract][Full Text] [Related]
18. Lower levels of leptin are associated with severity parameters in visceral leishmaniasis patients.
Fievez AMDC; Silva-Freitas ML; Sousa AQ; Santos-Oliveira JR; Da-Cruz AM
PLoS One; 2019; 14(3):e0214413. PubMed ID: 30913261
[TBL] [Abstract][Full Text] [Related]
19. 15d-Prostaglandin J2 induced reactive oxygen species-mediated apoptosis during experimental visceral leishmaniasis.
Vishwakarma P; Parmar N; Yadav PK; Chandrakar P; Kar S
J Mol Med (Berl); 2016 Jun; 94(6):695-710. PubMed ID: 26830627
[TBL] [Abstract][Full Text] [Related]
20. Miltefosine triggers a strong proinflammatory cytokine response during visceral leishmaniasis: role of TLR4 and TLR9.
Mukherjee AK; Gupta G; Adhikari A; Majumder S; Kar Mahapatra S; Bhattacharyya Majumdar S; Majumdar S
Int Immunopharmacol; 2012 Apr; 12(4):565-72. PubMed ID: 22361489
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]